Patents by Inventor Guido Bernhard Edmund Radtke

Guido Bernhard Edmund Radtke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160095819
    Abstract: The invention relates to oral pharmaceutical compositions containing flibanserin, methods for the preparation thereof and use thereof as a medicament.
    Type: Application
    Filed: September 28, 2015
    Publication date: April 7, 2016
    Inventors: Thomas Friedl, Guido Bernhard Edmund Radtke
  • Patent number: 9089488
    Abstract: The invention relates to an improved process for preparing a new medicament formulation of the active substance dabigatran etexilate of formula I in the form of the methanesulphonic acid salt thereof, and this new medicament formulation as such.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: July 28, 2015
    Assignee: Boehringer Ingelheim International GmbH
    Inventor: Guido Bernhard Edmund Radtke
  • Publication number: 20150004228
    Abstract: The invention relates to oral pharmaceutical compositions containing flibanserin, methods for the preparation thereof and use thereof as a medicament.
    Type: Application
    Filed: May 5, 2014
    Publication date: January 1, 2015
    Inventors: Thomas Friedl, Guido Bernhard Edmund Radtke
  • Publication number: 20130251811
    Abstract: The invention relates to an improved process for preparing a new medicament formulation of the active substance dabigatran etexilate of formula I in the form of the methanesulphonic acid salt thereof, and this new medicament formulation as such.
    Type: Application
    Filed: May 21, 2013
    Publication date: September 26, 2013
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventor: Guido Bernhard Edmund RADTKE
  • Publication number: 20110123635
    Abstract: The invention relates to an improved process for preparing a new medicament formulation of the active substance dabigatran etexilate of formula I in the form of the methanesulphonic acid salt thereof, and this new medicament formulation as such.
    Type: Application
    Filed: July 13, 2009
    Publication date: May 26, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventor: Guido Bernhard Edmund Radtke
  • Publication number: 20040048877
    Abstract: The invention relates to oral pharmaceutical compositions containing flibanserin, methods for the preparation thereof and use thereof as a medicament.
    Type: Application
    Filed: May 22, 2003
    Publication date: March 11, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Thomas Friedl, Guido Bernhard Edmund Radtke